Literature DB >> 15024061

ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Sylvie Duflot1, Bárbara Riera, Sonia Fernández-Veledo, Vicent Casadó, Robert I Norman, F Javier Casado, Carme Lluís, Rafael Franco, Marçal Pastor-Anglada.   

Abstract

This study describes a novel mechanism of regulation of the high-affinity Na(+)-dependent adenosine transporter (CNT2) via the activation of A(1) adenosine receptors (A(1)R). This regulation is mediated by the activation of ATP-sensitive K(+) (K(ATP)) channels. The high-affinity Na(+)-dependent adenosine transporter CNT2 and A(1)R are coexpressed in the basolateral domain of the rat hepatocyte plasma membrane and are colocalized in the rat hepatoma cell line FAO. The transient increase in CNT2-mediated transport activity triggered by (-)-N(6)-(2-phenylisopropyl)adenosine is fully inhibited by K(ATP) channel blockers and mimicked by a K(ATP) channel opener. A(1)R agonist activation of CNT2 occurs in both hepatocytes and FAO cells, which express Kir6.1, Kir6.2, SUR1, SUR2A, and SUR2B mRNA channel subunits. With the available antibodies against Kir6.X, SUR2A, and SUR2B, it is shown that all of these proteins colocalize with CNT2 and A(1)R in defined plasma membrane domains of FAO cells. The extent of the purinergic modulation of CNT2 is affected by the glucose concentration, a finding which indicates that glycemia and glucose metabolism may affect this cross-regulation among A(1)R, CNT2, and K(ATP) channels. These results also suggest that the activation of K(ATP) channels under metabolic stress can be mediated by the activation of A(1)R. Cell protection under these circumstances may be achieved by potentiation of the uptake of adenosine and its further metabolization to ATP. Mediation of purinergic responses and a connection between the intracellular energy status and the need for an exogenous adenosine supply are novel roles for K(ATP) channels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024061      PMCID: PMC371120          DOI: 10.1128/MCB.24.7.2710-2719.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae.

Authors:  J R Martens; N Sakamoto; S A Sullivan; T D Grobaski; M M Tamkun
Journal:  J Biol Chem       Date:  2000-12-13       Impact factor: 5.157

Review 2.  Emerging roles of purinergic signaling in gastrointestinal epithelial secretion and hepatobiliary function.

Authors:  R M Roman; J G Fitz
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

3.  Molecular characterization of volume-sensitive SK(Ca) channels in human liver cell lines.

Authors:  Richard Roman; Andrew P Feranchak; Marlyn Troetsch; Jeffrey C Dunkelberg; Gordon Kilic; Thorsten Schlenker; Jerome Schaack; J Gregory Fitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-01       Impact factor: 4.052

4.  Regulation of K(+) current in human airway epithelial cells by exogenous and autocrine adenosine.

Authors:  A J Szkotak; A M Ng; J Sawicka; S A Baldwin; S F Man; C E Cass; J D Young; M Duszyk
Journal:  Am J Physiol Cell Physiol       Date:  2001-12       Impact factor: 4.249

5.  Electrogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside transporter 1 (hCNT1) expressed in Xenopus laevis oocytes.

Authors:  M P Lostao; J F Mata; I M Larrayoz; S M Inzillo; F J Casado; M Pastor-Anglada
Journal:  FEBS Lett       Date:  2000-09-15       Impact factor: 4.124

6.  Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells.

Authors:  A Felipe; R Valdes; B Santo; J Lloberas; J Casado; M Pastor-Anglada
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  KATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting.

Authors:  H Malhi; A N Irani; P Rajvanshi; S O Suadicani; D C Spray; T V McDonald; S Gupta
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

8.  Mechanisms of delayed preconditioning with A1 adenosine receptor activation in porcine coronary smooth muscle cells.

Authors:  Mohammed A Nayeem; S Jamal Mustafa
Journal:  Pol J Pharmacol       Date:  2002 Sep-Oct

Review 9.  Adenosine in the central nervous system: release mechanisms and extracellular concentrations.

Authors:  S Latini; F Pedata
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

10.  A1 adenosine receptors of bovine brain couple to guanine nucleotide-binding proteins Gi1, Gi2, and Go.

Authors:  R Munshi; I H Pang; P C Sternweis; J Linden
Journal:  J Biol Chem       Date:  1991-11-25       Impact factor: 5.157

View more
  14 in total

1.  All-trans-retinoic acid promotes trafficking of human concentrative nucleoside transporter-3 (hCNT3) to the plasma membrane by a TGF-beta1-mediated mechanism.

Authors:  Paula Fernández-Calotti; Marçal Pastor-Anglada
Journal:  J Biol Chem       Date:  2010-02-19       Impact factor: 5.157

2.  Bile acids alter the subcellular localization of CNT2 (concentrative nucleoside cotransporter) and increase CNT2-related transport activity in liver parenchymal cells.

Authors:  Sonia Fernández-Veledo; Isabel Huber-Ruano; Ivette Aymerich; Sylvie Duflot; F Javier Casado; Marçal Pastor-Anglada
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Opioid receptor-independent protection of ischemic rat hepatocytes by morphine.

Authors:  Jae-Sung Kim; John J Lemasters
Journal:  Biochem Biophys Res Commun       Date:  2006-11-07       Impact factor: 3.575

4.  Inhibition of histone deacetylase 7 reverses concentrative nucleoside transporter 2 repression in colorectal cancer by up-regulating histone acetylation state.

Authors:  Chaonan Ye; Kun Han; Jinxiu Lei; Kui Zeng; Su Zeng; Haixing Ju; Lushan Yu
Journal:  Br J Pharmacol       Date:  2018-10-04       Impact factor: 8.739

Review 5.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 6.  Concentrative nucleoside transporters (CNTs) in epithelia: from absorption to cell signaling.

Authors:  M Pastor-Anglada; E Errasti-Murugarren; I Aymerich; F J Casado
Journal:  J Physiol Biochem       Date:  2007-03       Impact factor: 4.158

7.  Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs.

Authors:  Ekaitz Errasti-Murugarren; Marçal Pastor-Anglada; F Javier Casado
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

Review 8.  Metabolic Aspects of Adenosine Functions in the Brain.

Authors:  Mercedes Garcia-Gil; Marcella Camici; Simone Allegrini; Rossana Pesi; Maria Grazia Tozzi
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810

9.  Impaired glucose tolerance in the absence of adenosine A1 receptor signaling.

Authors:  Robert Faulhaber-Walter; William Jou; Diane Mizel; Lingli Li; Jiandi Zhang; Soo Mi Kim; Yuning Huang; Min Chen; Josephine P Briggs; Oksana Gavrilova; Jurgen B Schnermann
Journal:  Diabetes       Date:  2011-08-10       Impact factor: 9.461

10.  mTOR signaling regulates the processing of pre-rRNA in human cells.

Authors:  Valentina Iadevaia; Ze Zhang; Eric Jan; Christopher G Proud
Journal:  Nucleic Acids Res       Date:  2011-11-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.